Neoadjuvant bevacizumab (B) and trastuzumab (T) in combination with weekly paclitaxel (P) as neoadjuvant treatment in HER2-positive breast cancer: Results from a phase II trial (AVANTHER).
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Maria Fernandez Abad, Isabel Calvo, Noelia Martinez, Mercedes Herrero, Yolanda Quijano, Hipolito Duran, Mariola Garcia Aranda, Ana Suárez, Fernando López-Ríos, Diego Perez, Sofia Perea, Manuel Hidalgo, Laura García-Estevez
Institutions: Hospital Universitario Ramón y Cajal, Hospital Costa del Sol
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2948742035